Pharma Stocks Sank. Eli Lilly Fell 7%; Moderna Fell 5%; Novavax And BioNTech Fell 4%; Viking Fell 2%
Pharma Stocks Sank. Eli Lilly fell 7%; Moderna fell 5%; Novavax and BioNTech fell 4%; Viking fell 2%.
Eli Lilly cut its full-year earnings outlook citing research costs and CVS Health Corp. announced a deal to make its rival’s weight-loss drug more widely available.
In its first quarter, Lilly’s weight-loss drug performed in line with Wall Street’s expectations, a result that underwhelmed investors who’d been hoping for more explosive growth. Also Thursday, CVS Health Corp. announced it negotiated a deal that makes rival Novo Nordisk A/S’s weight loss drug cheaper for health plans, which has the potential to hurt Lilly’s future sales.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Most Discussed
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10